Chemotherapy affects immune cell landscape in pancreatic cancer: Study https://ift.tt/5ucOh2T

Published in the journal Nature Communications online Feb.13, the study analyzed more than 139,000 tumor cells collected from 27 patients with pancreatic ductal adenocarcinoma (PDAC), a hard to detect and treat cancer, with only 12 per cent of patients surviving longer than five years after diagnosis. According to researchers, a strong immune response to tumors in the tissue surrounding them is critical to shrinking these tumors in the pancreas.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cFJms79